Why is the clinical research industry so slow to adopt new technologies when the outcome is more effective treatments to patients faster? It's not the promise of the technology that is the barrier, it's catalyzing the change needed to implement.

Clinical leaders have to navigate the complexities of implementation by understanding how the adoption/application of innovative technologies minimizes risk in clinical trials, and how to effectively convey that message to ensure buy-in from stakeholders, both internal and external.

URL:

Tickets: https://go.evvnt.com/2433079-0?pid=91 

Price:

PHARMACEUTICAL / MEDICAL DEVICE / BIOTECH COMPANIES: USD 695.00